Sector
PharmaceuticalsOpen
₹4,619.5Prev. Close
₹4,572.2Turnover(Lac.)
₹19,477.65Day's High
₹4,666Day's Low
₹4,557.952 Week's High
₹4,712.952 Week's Low
₹3,140.1Book Value
₹249.73Face Value
₹5Mkt Cap (₹ Cr.)
1,54,710.18P/E
69.99EPS
65.37Divi. Yield
0.834 Jul 2025
12:00 AM
AGM
Announcement Date: 04 Jul, 2025
9 May 2026
12:00 AM
Board Meeting
Agenda : Audited Result
22 May 2026
12:00 AM
Dividend
Dividend Amount: 9
Record Date: 29 May, 2026
27 Mar 2026
12:00 AM
EGM
Here are some of the stocks that may see significant price movement today: Tata Power, Rail Vikas Nigam, Torrent Power, etc.
Here are some of the stocks that may see significant price movement today: Force Motors, Bajaj Auto, Ashoka Buildcon, etc.
Torrent Urja, is a wholly owned subsidiary of Torrent Green Energy Pvt. Ltd. The company is incorporated to develop a solar-plus-wind power project.
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 169.23 | 169.23 | 169.23 | 169.23 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 8,282.94 | 7,423.27 | 6,659.53 | 6,286.73 |
Net Worth | 8,452.17 | 7,592.5 | 6,828.76 | 6,455.96 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 6,742.32 | 6,450.57 | 6,168.44 | 4,248.24 |
yoy growth (%) | 4.52 | 4.57 | 45.19 | -7.49 |
Raw materials | -1,907.5 | -1,669.67 | -1,637.45 | -1,115.69 |
As % of sales | 28.29 | 25.88 | 26.54 | 26.26 |
Employee costs | -1,097.93 | -1,097.12 | -1,061.76 | -826.07 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 1,466.21 | 1,366.11 | 1,116.77 | 562.13 |
Depreciation | -602.43 | -609.84 | -606.66 | -383.88 |
Tax paid | -474.76 | -228.26 | -178.26 | -80.09 |
Working capital | -48.68 | 274.86 | 692.18 | 68.94 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 4.52 | 4.57 | 45.19 | -7.49 |
Op profit growth | -4.15 | 14.33 | 111.26 | -19.49 |
EBIT growth | 0.13 | 9.88 | 80.79 | -26.05 |
Net profit growth | -12.86 | 21.24 | 94.69 | -43.56 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 13,753 | 11,317 | 10,562 | 9,464 | 8,419 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 13,753 | 11,317 | 10,562 | 9,464 | 8,419 |
Other Operating Income | 227 | 199 | 166 | 156 | 89 |
Other Income | -94 | 23 | 146 | 45 | 197 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,807.7 | 144.46 | 4,33,619.81 | 608.7 | 0.89 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,638 | 66.14 | 1,76,086.64 | 756 | 0.45 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,571.2 | 69.99 | 1,54,837.1 | 467 | 0.83 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,389.4 | 32.59 | 1,12,193.56 | 384.64 | 0.94 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,104.7 | 30.09 | 1,11,123.45 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman/ED & CEO
Samir Mehta
ED / MD / Promoter
Aman Mehta
Non-Exec & Non-Independent Dir
Jindal Mehta
Lead Independent Non Executive Director
Manish Choksi
Independent Non Exe. Director
Ameera Sushil Shah
Independent Non Exe. Director
Nayantara Bali
Independent Non Exe. Director
Nikhil Khattau
Company Sec. & Compli. Officer
Chintan M. Trivedi
Chairman Emeritus
Sudhir Mehta
Torrent House,
Off Ashram Road,
Gujarat - 380009
Tel: 91-79-26599000
Website: http://www.torrentpharma.com
Email: investorservices@torrentpharma.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@karvy.com
Summary
Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments. The Company has established itself as a lead...
Read More
Reports by Torrent Pharmaceuticals Ltd
What is the Torrent Pharmaceuticals Ltd share price today?
What is the Market Cap of Torrent Pharmaceuticals Ltd?
What is the PE and PB ratio of Torrent Pharmaceuticals Ltd?
What is the 52 Week High and Low of Torrent Pharmaceuticals Ltd?
What is the CAGR of Torrent Pharmaceuticals Ltd?
What is the shareholding pattern of Torrent Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
